Cardiovascular data on endpoints like MACE-3 or MACE-4 are presently not available yet, but an early meta-analysis demonstrated at least cardiovascular safety in patients with T2D treated with tirzepatide (78, 79)
I break down the labs that matter more for many people, including LDL particle quality (NMR testing), triglycerides, inflammation markers, and blood sugar markers that often tell the deeper story
And the amount of muscle loss during weight loss can dramatically influence metabolism, strength, long-term health, and how sustainable those results actually are
As a matter of fact, in 2019, an oral GLP-1 receptor agonist called semaglutide was approved for type 2 diabetes treatment in the United States and Europe
According to the company, people will be able to get single-dose vials with a prescription from a Ro-affiliated healthcare professional
Like any powerful treatment, it can come with side effectsbut with the right support, those side effects are often short-lived and manageable
